IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tetragon Partners GP Ltd

Q3 2018 Holdings

Filed 2018-11-14 | 59 holdings | $29.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Teladoc Health IncNOTE 3.000% 12/187918AAB1$48.8K$23,500,0000.2%
Renewable Energy Group IncNOTE 4.000% 6/175972AAC7$66.4K$24,250,0000.2%
Ligand Pharmaceuticals IncNOTE 0.750% 8/153220KAD0$101.0K$29,500,0000.3%
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$4.1M300,00014.0%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$24.2M790,15083.3%
PreviousPage 2 of 2